HUGE Stock Overview
About the company
FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD201, a palmitoylethanolamide for the treatment of inflammatory diseases. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders; and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma Inc. is headquartered in Toronto, Canada.
Snowflake Analysis
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
FSD Pharma Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$1.95 |
| 52 Week High | CA$2.57 |
| 52 Week Low | CA$0.92 |
| Beta | 0.89 |
| 1 Month Change | -20.41% |
| 3 Month Change | 85.71% |
| 1 Year Change | 77.27% |
| 3 Year Change | -59.46% |
| 5 Year Change | n/a |
| Change since IPO | -91.92% |
Recent News & Updates
Recent updates
Shareholder Returns
| HUGE | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -0.5% | -3.5% | 0.7% |
| 1Y | 77.3% | -63.1% | -12.0% |
Return vs Industry: HUGE exceeded the Canadian Pharmaceuticals industry which returned -63.1% over the past year.
Return vs Market: HUGE exceeded the Canadian Market which returned -12% over the past year.
Price Volatility
| HUGE volatility | |
|---|---|
| HUGE Average Weekly Movement | 9.5% |
| Pharmaceuticals Industry Average Movement | 12.6% |
| Market Average Movement | 9.2% |
| 10% most volatile stocks in CA Market | 18.0% |
| 10% least volatile stocks in CA Market | 3.8% |
Stable Share Price: HUGE is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: HUGE's weekly volatility (10%) has been stable over the past year.
FSD Pharma Inc. Fundamentals Summary
| HUGE fundamental statistics | |
|---|---|
| Market Cap | CA$87.36m |
| Earnings (TTM) | -CA$36.50m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-2.2x
P/E RatioIs HUGE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HUGE income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$26.72m |
| Earnings | -US$26.72m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.66 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.8% |
How did HUGE perform over the long term?
See historical performance and comparison